CBD Use and Liver Injury: Practical Considerations for Primary Care - Frankly Speaking Ep 339 - a podcast by Pri-Med

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-339

Overview: In this episode, we dive into a recent systematic review and meta-analysis confirming the association between cannabidiol (CBD) use and hepatotoxicity. Gain a deeper understanding of clinical applications and the delicate balance of risks and benefits when discussing CBD use with your patients.

Episode resource links:

• Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023 Mar 13. doi: 10.1111/joim.13627. Epub ahead of print. PMID: 36912195.


• https://store.samhsa.gov/sites/default/files/pep22-06-04-003.pdf

Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato

Further episodes of Frankly Speaking About Family Medicine

Further podcasts by Pri-Med

Website of Pri-Med